ライフサイエンスコーパス: adeno-associated virus vector

1 interference (RNAi) cassette delivered by an adeno-associated virus vector.

2 nly in hepatocytes, due to infection with an adeno-associated virus vector.

3 oloney murine leukemia virus, adenovirus, or adeno-associated virus vector.

4 assemblies, similar to the best recombinant adeno-associated virus vectors.

5 28-fold that obtained using single-stranded adeno-associated virus vectors.

6 blastic cells using herpes simplex virus and adeno-associated virus vectors.

7 ty and tolerability of escalated doses of an adeno-associated virus vector (AAV) expressing a normal

8 We used a recombinant adeno-associated virus vector (AAV) to deliver a foreign

9 Recombinant adeno-associated virus vectors (AAV) were prepared in hi

10 es simplex virus vector, HSV.CMVlac, and the adeno-associated virus vector, AAV.CMVlac, is affected b

11 very of anti-N-terminal htt scFv-C4 using an adeno-associated virus vector (AAV2/1) significantly red

12 An adeno-associated virus vector (AAV9) for alpha-synuclein

13 protein tau to the substantia nigra using an adeno-associated virus vector (AAV9).

14 Apart from their therapeutic potential, adeno-associated virus vectors also represent outstandin

15 cus aureus) and guide RNA constructs into an adeno-associated virus vector and systemically delivered

16 sfer by nonspecifically bound adenovirus and adeno-associated virus vectors and by a modified adenovi

17 either singly or in combination by employing adeno-associated virus vectors and then challenged with

18 Recombinant adeno-associated virus vectors based on serotype 2 (rAAV

19 Recombinant adeno-associated virus vectors based on serotype 6 (rAAV

20 encies in vivo, we constructed a recombinant adeno-associated virus vector carrying the NDI1 gene (rA

21 Administration of rTMD1 or recombinant adeno-associated virus vector carrying TMD1 could be a p

22 Intrahippocampal injections of adeno-associated virus vectors containing the astrocyte-

23 the use of a dominant-negative forkhead boxO adeno-associated virus vector delivered directly to the

24 We used adeno-associated virus vector-delivered siRNAs to select

25 novel treatment strategy with a recombinant adeno-associated virus vector delivering a modified FVII

26 ive vaccination strategy whereby recombinant adeno-associated virus vectored delivery of anti-prion s

27 A recombinant adeno-associated virus vector encoding human delta-sarco

28 therapy of CML, we constructed a recombinant adeno-associated virus vector encoding the p210(BCR-ABL)

29 xpression system, we generated a recombinant adeno-associated virus vector encoding the VEGFR2-neutra

30 r the use of DCs transduced with recombinant adeno-associated virus vectors encoding multiepitope imm

31 developed adult brain, we have generated an adeno-associated virus vector expressing a small hairpin

32 ingle intraportal injection of a recombinant adeno-associated virus vector expressing factor IX succe

33 Administration of a self-complementary Adeno-Associated Virus vector expressing full-length SMN

34 We transduced NAcore astrocytes with an adeno-associated virus vector expressing hM3D designer r

35 directed gene therapy with a single-stranded adeno-associated virus vector expressing human Factor IX

36 uring early AD-like pathology, a recombinant adeno-associated virus vector expressing TNF-alpha was s

37 proach to assess the efficacy of recombinant adeno-associated virus vectors expressing inducible IL-2

38 t NOD scid gamma (NSG) mice by the use of an adeno-associated virus vector, followed by engraftment o

39 latory system involving a single recombinant adeno-associated virus vector harboring two expression c

40 we show that expression of these genes from adeno-associated virus vectors in C57BL/6 mice is able t

41 Clenbuterol along with a low-dose adeno-associated virus vector increased Rotarod latency

42 the nuclei of retinal ganglion cells via an adeno-associated virus vector injected into the vitreous

43 e correction mediated by a limited number of adeno-associated virus vector injections in the cat mode

44 These observations suggest that adeno-associated virus vectors may be used to modify tro

45 demonstrate that a combined adeno virus and adeno-associated virus vector-mediated gene transfer lea

46 gnaling in a common mouse model of AD, using adeno-associated virus vectors normalized glutamate sign

47 d, we have generated a series of recombinant adeno-associated virus vectors of serotypes 1 and 5 enco

48 ing co-injection of two separate recombinant adeno-associated virus vectors, one encoding an inducibl

49 A mixture of two adeno-associated virus vectors, one expressing the trans

50 This is achieved using a specialized adeno-associated virus vector optimized for the producti

51 We introduced recombinant adeno-associated virus vector (rAAV) carrying a lacZ rep

52 Recombinant adeno-associated virus vector (rAAV) incorporating a con

53 Recombinant adeno-associated virus vectors (rAAV) show promise in pr

54 tically enhances transduction by recombinant adeno-associated virus vectors (rAAV).

55 through delivery of a serotype-1 recombinant adeno-associated virus vector (rAAV1-IFNgamma).

56 acerebral administration of a Ngb-expressing adeno-associated virus vector reduces infarct size and i

57 mophilia A in dogs, and that double-stranded adeno-associated virus vectors resulted in expression of

58 of mice, by using a replication-incompetent adeno-associated virus vector, results in tumours with a

59 human patients, and gene augmentation using adeno-associated virus vectors robustly sustained the re

60 In contrast to other gene delivery systems, adeno-associated virus vectors show long term gene expre

61 ts within the packaging limit of recombinant adeno-associated virus vectors that have been shown to b

62 We used an adeno-associated virus vector to achieve targeted insert

63 Here, we have used adeno-associated virus vectors to disrupt dominant-negat

64 The use of adeno-associated virus vectors to express short-hairpin

65 Using an inducible recombinant adeno-associated virus vector, we investigated the effec

66 Here we compare the effects of adeno-associated virus vectors with neurotrophin gene in

67 o circumvent this toxicity, we developed new adeno-associated virus vectors with skeletal muscle-rest

68 review the main molecular characteristics of adeno-associated virus vectors, with a particular view t